The Investor Relations website contains information about Fortrea's business for stockholders, potential investors, and financial analysts.
Location: United States, North Carolina, Durham
Employees: 10001+
Founded date: 2023
Mentions in press and media 11
| Date | Title | Description |
| 12.09.2024 | The Future of Obesity Treatment: A New Era in Drug Development | Obesity is a complex beast. It’s not just about overeating or lack of exercise. It’s a chronic disease, a multifaceted challenge that affects millions. As we dive into the world of obesity drug development, we see a landscape shifting rapid... |
| 11.09.2024 | Creating Software as a Medical Device (SaMD) Technology in the Ever Changing Regulatory Environment, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this free webinar, learn about the current landscape in software as a medical device (SaMD) development. Attendees will learn about the applicable standards, guidance documents and regulations. The featured speakers will ... |
| 10.09.2024 | Amid Record Growth and Adoption of Judi Clinical Trial Collaboration Platform, AG Mednet Announces New Key Leadership Appointments | BOSTON, Sept. 10, 2024 /PRNewswire/ -- AG Mednet, the pioneering force in clinical trial process management, continues to experience rapid growth and momentum, driven by the widespread adoption of its Judi platform on over 2,000 clinical tr... |
| 05.09.2024 | New Era of Obesity Drug Development, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this webinar, learn about obesity's health burden and the evolution of drug development in obesity. The speakers will discuss about the importance of preservation of muscle mass for long term weight maintenance. They will... |
| 25.06.2024 | Patient Centricity in Neurodegenerative Diseases, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this free webinar, take a deep dive into the current advancements in patient-centric precision medicine for neurogenerative diseases. Attendees will gain insights into the treatments for neurodegenerative disorders and th... |
| 05.06.2024 | Exploring Applications of CAR-T Therapy Outside Oncology: Strategies for Applying Lessons Learned, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this webinar, learn about the nature of CAR-T therapy and how the transition from oncology to non-oncology indications presents challenges and complexities in running clinical trials. Attendees will understand the latest ... |
| 09.05.2024 | Advancing CGT Trial Ecosystems in the Asia-Pacific Region, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this free webinar, learn about the evolving landscape in cell and gene therapy (CGT) industry as well as regulatory framework in major CGT markets in the Asia-Pacific (APAC) region. Attendees will learn about navigating t... |
| 30.04.2024 | Accelerating Clinical Development through Design, Diversity & Digitalization in Oncology and Beyond, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this free webinar, attendees will gain insights into novel approaches to keep clinical development on track. Hear about how these strategies can boost diversity, equity and inclusion (DEI), from real-world examples to sup... |
| 22.04.2024 | Get Your Study Enrolled - Designing Your Impairment Protocol to Prevent Challenges, Upcoming Webinar Hosted by Xtalks | www.fortrea.com In this free webinar, learn how renal impairment study protocols can be improved to maximize patient enrollment. Attendees will understand design considerations around mild, moderate and/or severe populations, and the result... |
| 12.03.2024 | Durham’s Fortrea to divest two businesses for $345M | Fortrea, a global contract research organization (CRO) that was spun off of Burlington-based Labcorp in 2023, will divest two of its businesses to focus more on supporting clinical drug development in phases 1 through 4. Fortrea, headquarte... |
Show more